Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LEAD-2 trial of liraglutide added to metformin in type 2 diabetes mellitus
2005-003417-32Phase 3Completed
- Sponsor
- Novo Nordisk
- Start
- Jan 2006
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 3 trial of liraglutide in type 2 diabetes mellitus (T2DM) (3 arms), sponsored by Novo Nordisk. Primary endpoint: HbA1c. Started Jan 2006; status: completed.
02
Drugs
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2005-003417-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-003417-32.